Latest Market News

Imugene has dosed the first patient in a new cohort combining its azer-cel CAR T therapy with BTK inhibitors, targeting patients with B-cell malignancies who failed prior BTKi treatment. This move broadens the trial’s scope and tackles a significant unmet need in blood cancer therapy.

Peet Limited has upgraded its FY26 net profit guidance by up to 17%, driven by accelerated construction and robust market demand in Western Australia and Queensland.

Aspermont Limited (ASX:ASP) reported a 147% jump in net profit and 11% revenue growth for H1 FY26, driven by steady subscription growth and a ramp-up in non-subscription revenues. The company’s self-funded data and intelligence platform is on track, with Rio Tinto’s enterprise contract validating its strategic pivot.

Develop Global’s Pioneer Dome lithium project hits high-grade infill drilling results surpassing resource expectations, setting the stage for a Final Investment Decision next month on an 850,000-tonne DSO operation.

Beonic Ltd (ASX:BEO) has initiated a $3 million pro-rata renounceable entitlement offer at $0.08 per share, partially underwritten by Alpine Capital, to shore up working capital and repay shareholder loans. The offer carries potential dilution of 35.7% for non-participating shareholders and may increase the Thorney Group's voting power significantly.

Tetratherix Limited secures $15 million via institutional placement plus a capped $2 million share purchase plan at a 14% discount, aiming to fast-track manufacturing expansion and commercial partnerships.

Select Harvests delivered a 33% rise in underlying NPAT despite a wet harvest and higher costs, announcing a fully franked interim dividend and a 10% on-market share buy-back.

Sunshine Metals has secured $7.7 million through an oversubscribed Share Purchase Plan, exceeding its $3 million target, to fund the Mt Moss processing facility acquisition and Liontown mine start-up.

Australian Clinical Labs appoints Greg Horan as Group CEO effective August 2026, marking a leadership transition after a decade under Melinda McGrath. Horan’s healthcare and operational expertise positions ACL for its next growth phase.

OncoSil Medical has secured a pivotal ethics committee approval in Italy, reclassifying its OSPRItaly registry and enabling a streamlined procurement process that could double the number of authorised hospitals using its OncoSil™ device by mid-2027.

Acrux has amended its licensing agreement with Gedeon Richter to bring its Estradiol spray Lenzetto® to Australia, unlocking up to AUD 5.4 million in milestone payments and addressing a critical shortage in Menopause Hormone Therapy products.

Jameson Resources has cleared a major environmental hurdle for its Crown Mountain steelmaking coal project, receiving the Section 27 Notice from British Columbia regulators and setting the stage for final application submission in October 2026.